Congress Materials

Medical Information
Ireland
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a healthcare professionalYes, I am a healthcare professional
SelectI am a healthcare professionalYes, I am a healthcare professional
I am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal
SelectI am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal

If you don't reside in Ireland, please click here

The medical information on this site is intended only for healthcare professionals in the Republic of Ireland. The products discussed herein may have different product labeling in other countries.

This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Campling J, Begier E, Lahuerta M, De Melo A, Vyse A, Southern J, Valluri S, Hyams C, Finn A, Slack M, Gessner B, Ellsbury G April 18, 2023 ECCMID 2023 Pneumococcal Disease

Adult hospitalised community acquired pneumonia incidence in Bristol, UK: Comparison of retrospective ICD-10 based analysis and prospective study data collected during the COVID-19 pandemic.

View Presentation
Poster
Grant L, Begier E, Theilacker C, Barry R, Hall-Murray C, Yan Q, Pope V, Pride M, Jodar L, Gessner B April 18, 2023 ECCMID 2023 Pneumococcal Disease

Contribution of urine-based assays to detection of S. pneumoniae and S. pneumoniae serotypes among adults with community-acquired pneumonia

View Presentation
Poster
Huang L, de los Angeles Gutierrez M, Luis Huerta J April 18, 2023 ECCMID 2023 Pneumococcal Disease

Cost-effectiveness of vaccinating adults > 65 years with the 13-valent pneumococcal conjugate vaccine in Mexico

View Presentation
Poster
Shigayeva A, Farooqi L, Kandel C, Zhong Z, Coleman B, Mubareka S, Barati S, Gilbert L, Gingras A-C, Gold W, Haq N, Katz K, Kim P, Lefebvre M, Li A, Major M, Mazzulli T, Powis J, Rizvi S, Quadri A, Sultana A, Vojicic J, Yang J, Zhang P, Martin C, Kyaw M, McLaughlin J, McGeer A April 18, 2023 ECCMID 2023 Coronovirus Disease

COVID-19 infection early in the pandemic and protection from infection during the Omicron BA.1/BA.2 waves in Ontario, Canada

View Presentation
Oral Presentation
RL Lapidot, A Averin, L Huang, J Vietri, A Arguedas, A Cane, D Weycker, SI Pelton April 18, 2023 ECCMID 2023 Pneumococcal Disease

Disparities by age, comorbidity, and insurance type in the burden of invasive pneumococcal disease and respiratory syndromes in children in the United States

View Presentation
Poster
Sepúlveda-Pachón I, Theilacker C, Dunne E, Hanquet G, Baay M, Menon S, Gessner B April 18, 2023 ECCMID 2023 Pneumococcal Disease

Effect of pneumococcal conjugate vaccines on viral respiratory infections in children: a systematic literature review

View Presentation
Oral Presentation
Donskey C, Liles E, Szymokowiak K, Lawrence J, Bouguermouh S, Zhang H, Koury K, Kitchin N, Bailey R, Smith H, Kalina W, Klein N, Dubberke E, Wilcox M, Martin E, Pride M, Anderson A, Gruber W, Jansen K, Lockhart S, Webber C April 18, 2023 ECCMID 2023 Clostridium Difficile

Efficacy and safety of Clostridioides difficile vaccine in adults ≥ 50 years old: Results from the CLOVER trial

View Presentation
Poster
Liapikou A, Milionis H, Tsimihodimos V, Konstantinidis A, Baxevanos G, Terrovitou C, Triantafyllidis C, Kossyvaki V, Skiadas J, Markatis L, Menegas D, Méndez C, Schwarz C, Lahuerta M, Begier E, Gessner B, Toumbis M and the EGNATIA Study Group April 18, 2023 ECCMID 2023 Pneumococcal Disease

EGNATIA study: Comparing patients with pneumococcal versus non-pneumococcal hospitalized community-acquired pneumonia over a 3-year period

View Presentation
Oral Presentation
Yoshii K, Ohira M, Takano A, Aso Y, Nakajima H, Kobayashi Y, Harper LR, Edwards J, Bender C, Pilz, A, Wada K, Angulo FJ, Erber W, Madhava H, Moïsi JC, Jodar L, Takao M April 18, 2023 ECCMID 2023 Tick-borne encephalitis

Tickborne Encephalitis (TBE) in two patients with acute encephalitis or meningitis of previously unknown etiology in Japan: First evidence of TBE in Japan outside of the island of Hokkaido

View Presentation
Poster
Freimane Z, Karelis G, Harper LR, Bender C, Zhang P, Pilz, A, Angulo FJ, Erber W, Bormane A, Madhava H, Moïsi JC, Jodar L, Zavadska D April 18, 2023 ECCMID 2023 Tick-borne encephalitis

Vaccine effectiveness of tick-borne encephalitis vaccines for the prevention of hospitalized tick-borne encephalitis infections in Latvia, 2018-2020

View Presentation